loading page

Catheter Radiofrequency Ablation of Recurrent Para-Hisian Accessary Pathways with Near Zero X-ray Exposure
  • +3
  • Peng Wang,
  • Feng Hu,
  • Zhimin Liu,
  • Guodong Niu,
  • Gang Chen,
  • Yan Yan
Peng Wang
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College

Corresponding Author:[email protected]

Author Profile
Feng Hu
Fuwai Heart Hospital and Cardiovascular Institute, Peking Union Medical College - Chinese Academy of Medical Sciences
Author Profile
Zhimin Liu
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Author Profile
Guodong Niu
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Author Profile
Gang Chen
State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Author Profile
Yan Yan
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Author Profile

Abstract

Introduction Radiofrequency (RF) ablation of parahisian accessory pathways (PHAPs) is a serious challenge, which is associated with high recurrence and fluoroscopy exposure. According to previous studies and case reports, catheter ablation of PHAPs is associated with a high post-ablation recurrence. The aim of this study is to assess the efficacy, safety and long-term outcome of radiofrequency ablation in patients with recurrent PHAPs after prior ablations with zero or extremely low fluoroscopy. Methods and Results A total of 58 patients (43 male, 75.4%) with PHAPs that had one or more previously unsuccessful RF ablations were enrolled. RF ablation procedures were performed under a three-dimensional guiding system (EnSite NavX, St. Jude Medical, MN) with extremely low exposure of fluoroscopy to femoral venous or arterial routes. The acute success rate was 96.6% (56/58). Two procedures were terminated during ablation because of high risk of complete AVB. In addition to a case of transient complete AVB during RF energy delivery, no minor or major complications were recorded during the procedure or long-term follow up. The mean fluoroscopy time was 98 seconds (0-129), and the mean radiation dose was 1.98 mGy (0-3.38) in all 58 cases. Fourteen patients underwent the EPS and RF ablation with zero X-ray exposure. The long-term success rate was 98.2% with a median follow-up period of 30 (12-45) months. Conclusions With a near zero X-ray exposure, RF ablation of recurrent PHAPs can be performed with a high acute success rate and convincing safety during long-term follow-up.